Homing of endothelial progenitor cells (EPC) to the ischemic tissues is a key event in neovascularization and tissue regeneration. In response to ischemic insult, injured tissues secrete several chemo-cytokines, including stromal cell-derived factor-1α (SDF-1α), which triggers mobilization and homing of bone marrow-derived EPC (BMD-EPC). We previously reported that SDF-1α-induced EPC homing is mediated by a panel of adhesion molecules highly or selectively expressed on the activated endothelium in ischemic tissues, including E-selectin. Elevated E-selectin on wound vasculature serve as docking sites for circulating EPC, which express counterpart E-selectin ligands. Here, we show that SDF-1α presented in wound tissue and released into circulation can act both locally and remotely to induce ischemic tissue endothelium and BMD-EPC to express both E-selectin and its ligands. By performing BM transplantation using E-selectin−/− and E-selectin+/+ mice as the donors and recipients respectively, we demonstrate that upregulated dual E-selectin/ligand pairs reciprocally expressed on ischemic tissue endothelium and BMD-EPC act as double-locks to secure targeted EPC- endothelium interactions by which to facilitate EPC homing and promote neovascularization and tissue repair. These findings describe a novel mechanism for BMD-EPC homing and indicate that dual E-selectin/ligand pairs may be effective targets/tools for therapeutic neovascularization and targeted cell delivery.
Targeted homing of endogenously mobilized stem/progenitor cells and exogenously infused therapeutic stem cells from the circulation to injured tissue is a crucial event in stem cell-based therapy and stem cell-mediated tissue repair/regeneration1,2,3. Ischemic tissue-specific homing is triggered by a dynamic and coordinated multi-step paradigm involved in chemo-cytokines induced by low-oxygen sensor hypoxia-inducible factor-1α (HIF-1α). Among these chemo-cytokines, SDF-1α is a potent chemoattractant for trafficking and migration of stem and progenitor cells. SDF-1α can exert its role through binding with its cognate receptor C-X-C chemokine receptor 4 (CXCR4), which is expressed on the surface of EPC4,5 and it may function as a sensor for circulating EPC cruising through sites on the microvasculature in ischemic tissue that have an SDF-1α gradient. Inhibition of the SDF-1α/CXCR4 interaction is capable of blocking, although partially, the homing of progenitor/stem cells to the ischemic myocardium6,7. Because SDF-1α is a secreted soluble factor, even if it binds to CXCR4 on the surface of the circulating EPC, it would not directly mediate attachment of EPC to the endothelium. Under the shear force of the blood flow, circulating EPC would unlikely to be anchored on the endothelium in ischemic tissue. Although an early study reported that SDF-1α could form complexes in vitro with heparin sulfate, a glycosaminoglycan (GAG) found ubiquitously on the cell surfaces and in the extracellular matrix8,9, it is unknown whether SDF-1α can interact with cell-membrane-bound-GAG in vivo, especially with GAG on the endothelium under shear force. We previously reported a novel mechanism whereby SDF-1α regulates EPC homing. We demonstrated that SDF-1α can specifically induce the expression of E-selectin in luminal endothelial cells (EC) and elevated E-selectin is responsible for mediating EPC homing by enhancing adhesion of circulating EPC to luminal EC in ischemic tissue and subsequent transendothelial migration and extravasation. These effects resulted in a significant enhancement of wound neovascularization and repair in a mouse hind limb ischemia model10.
E-selectin is an inducible vascular adhesion molecule prevalently expressed on activated EC in response to inflammation and injury. Its role in the recruitment of circulating leukocytes11,12, hematopoietic stem cells (HSC)13 and EPC10,14,15 takes place mainly through association with its counterpart ligands, including PSGL-1/CD162, ESL-1 and CD44, expressed on these circulating cells. Recent studies, however, have begun to indicate the presence of E-selectin on murine BMD-EPC, even though the role of E-selectin on EPC has not yet been established14. The expression of PSGL-1/CD162 on the endothelium16, in particular on the endothelial lining of atherosclerotic coronary arteries has been reported17. This suggests a potential role in the formation of the inflammatory infiltrate in arterial wall lesions. In this way, reverses in the pattern of expression of E-selectin on EPC and E-selectin ligand on endothelium may also be involved in mediating EPC-EC interactions and EPC homing. Indeed, we have recently demonstrated that levels of CD44 are upregulated on the endothelium of acute wound bed capillaries and the elevated CD44 function as docking sites for wound tissue homing of infused exogenous cells which are installed with soluble E-selectin on cell surface18.
This study builds upon previous findings and shows that SDF-1α administrated and elevated in ischemic tissue can induce expression of E-selectin and its ligands in both local ischemic wound endothelium and remote BM EPC and circulating EPC. Upregulated dual E-selectin/ligand pairs reciprocally expressed on activated endothelium in ischemic wound tissue and mobilized BMD-EPC mediate EPC-EC interactions to promote targeted EPC homing, increased wound neovascularization and faster tissue repair.
SDF-1α supplied to ischemic wound tissue has a remote role in inducing E-selectin expression on BMD-EPC
Wound tissue SDF-1α, either secreted by local tissue cells in response to ischemic insult or therapeutically administrated, can be released into circulation. To study the remote effect of local SDF-1α in ischemic diabetic wound tissue on EPC resided in their BM niche and in circulation, ischemic hindlimb wounds were made in NOD mouse. Because the tissue levels of SDF-1α in diabetic murine wounds are significantly lower than in healthy tissue, as indicated in a previous study19, exogenous recombinant mouse SDF-1α (γmSDF-1α) (25 μg/kg, this dosage was determined in our previous study10) was injected into the wound bed. Equal volumes of solvent (PBS) were injected into wound bed in the control group (n = 8/group). Concentrations of SDF-1α in sera collected from the tail vein 4 h later were measured by ELISA. Local wound injection of γmSDF-1α resulted in elevated serum levels of SDF-1α compared with PBS injection in control mice (Fig. 1A), indicating the release of locally administrated γmSDF-1α into circulation. Elevated SDF-1α in sera can either stimulate circulating EPC or reach BM to stimulate EPC present in BM. Both BM and peripheral blood were harvested 24 h after wound tissue SDF-1α injection. Cells were incubated with FITC-CD34, APC-KDR and PE-E-selectin antibodies (Abs). E-selectin levels in the gated EPC (EPC are defined as CD34+/KDR+ herein) fraction were measured using flow cytometry analysis. In response to elevated systemic levels of SDF-1α, expression of E-selectin in EPC from BM (Fig. 1B) and peripheral blood (Fig. 1C) was significantly increased, showing that local supplementation of SDF-1α in ischemic wound tissue can have a remote effect on expression of E-selectin in BM and circulating EPC. SDF-1α also appeared to promote EPC mobilization in that there were approximately 1-fold more EPC in peripheral blood (Fig. 1C) in response to locally administrated SDF-1α. The comparable amounts of EPC in BM (Fig. 1B) suggested a quick self-renewal of EPC to maintain a stable BM EPC pool after EPC mobilization.
To confirm these observations, we conducted immunoblotting analyses and confirmed upregulation of E-selectin in recombinant human SDF-1α (γhSDF-1α)-stimulated human EPC in vitro (Fig. 1D). A RT2 Profiler™ PCR array was made to examine gene expression profile of expanded panel of cell adhesion molecules and extracellular matrix in EPC in response to SDF-1α. Of the 84 genes, 3 were downregulated (−) and 22 were upregulated (+) (cut-off value: < or >2-fold) (Supplemental Table 1) and 59 were unaltered. Notably, expression of the E-selectin gene was increased about 3.48-fold upon SDF-1α stimulation (Fig. 1E). PCR array data offered additional candidates for future elucidation of the mechanisms underlying SDF-1α-triggered BMD-EPC homing and mobilization.
Collectively, these data demonstrated that local administration of SDF-1α to ischemic wounds could have a remote effect on expression of E-selectin in BM and circulating EPC and mobilization of BMD-EPC.
SDF-1α induces cultured EC and mouse wound endothelium to express E-selectin ligands in vitro and in vivo
To determine whether wound endothelium expresses counterpart ligands of E-selectin in response to locally administrated γmSDF-1α in wound tissue, the expression of the E-selectin ligand CD44 was specifically examined in the microvasculature of ischemic hindlimb wounds of NOD mouse 24 h after wound bed injection of γmSDF-1α, because the presence of PSGL-1/CD162 on injured or inflamed endothelium has already been established17. We observed that CD44 expression in luminal EC was markedly higher in ischemic diabetic wounds than endothelium in the control hindlimb tissue (non-ischemia, PBS injection) of the same mouse (n = 8/group) (Fig. 2A), demonstrating that elevated SDF-1α in wound tissue caused the local endothelium to increase expression of the E-selectin ligand CD44.
Immunoblotting assays were performed to validate upregulation of E-selectin ligands by SDF-1α in EC. Increased protein expression of three E-selectin ligands, CD44, CD162 and ESL-1, in human microvascular endothelial cells (HMVEC) upon SDF-1α stimulation was confirmed (Fig. 2B).
E-selectin ligands can be expressed as unmodified inactive form or modified active form. The active form can associate with E-selectin. To determine whether SDF-1α-induced E-selectin ligands are in the inactive or active form, a cell surface E-selectin ligand binding assay was conducted to determine whether FITC-conjugated HECA452, which is mAb directed against a sialyl Lewis X (sLeX) epitope on active E-selectin ligand CD16220 and CD4421, can associate with SDF-1α-induced E-selectin ligands on HMVEC and EPC. It had already been demonstrated that SDF-1α also induces E-selectin ligands expressed in EPC10. Approximately 1-fold and 1.4-fold more FITC-HECA452 was found to be bound to SDF-1α-stimulated HMVEC (Fig. 2C) and EPC (Fig. 2D) compared to non-stimulated HMVEC and EPC, respectively, indicating that SDF-1α-induced E-selectin ligands expressed on HMVEC and EPC are modified as active form, which can be associated with HECA452. These experiments demonstrated that SDF-1α could cause HMVEC and EPC to express three E-selectin ligands, CD44, CD162 and ESL-1, which are likely to be modified into an active form.
Therefore, SDF-1α-induced E-selectin ligands expressed on the ischemic diabetic wound endothelium may serve as docking adhesion molecules to mediate anchorage of E-selectin+ circulating cells, for example, SDF-1α-triggered circulating EPC, on the activated endothelium.
Up-regulated E-selectin on EPC and E-selectin ligands on EC are responsible for mediating SDF-1α-induced EPC-EC interactions
We previously reported that SDF-1α induced EPC-EC adhesion in vitro, which is mediated by up-regulated E-selectin on EC and E-selectin ligands on EPC10. To determine whether SDF-1α-induced E-selectin on EPC and E-selectin ligands on EC, which have been identified in the current study, are also involved in mediating SDF-1α-enhanced EPC-EC adhesion, the effect of antagonists against E-selectin and its ligands on inhibition of SDF-1α-enhanced EPC adhesion to EC monolayer was tested in vitro. Human EPC were pre-labeled with Dil-Ac-LDL. Dil-Ac-LDL+ EPC were detached from dishes and cultured in agarose gel-coated dishes to prevent adhesion. These EPC were then stimulated with γhSDF-1α or BSA. After 4 h, Dil-Ac-LDL+ EPC were replaced with EGM2 medium containing either E-selectin neutralizing Ab or isotype-matched control Ab (2 μg/ml) and incubated for 15 min at 37 °C. HMVEC were grown as a monolayer and stimulated with γhSDF-1α or BSA for 4 h. The stimulated HMVEC monolayer was re-cultured in EGM2 media containing either soluble E-selectin (sE-sel) or BSA (2 μg/ml) and incubated for 15 min at 37 °C. After washing both EPC and HMVEC with PBS to remove un-associated E-selectin-neutralizing Ab or sE-sel, non-adherent Dil-Ac-LDL+ EPC were collected from agarose-gel-coated dishes and added to the wells containing the HMVEC monolayer to allow EPC-EC interactions. After 30 min, unbound EPC were washed out by PBS (twice) and Dil-Ac-LDL+ EPC associated with HMVEC-monolayers were measured using a fluorescence scanner. As in previous reports, SDF-1α-stimulated EPC and HMVEC monolayers showed significantly more EPC-EC binding capability than un-stimulated control cells (Fig. 3). Combined treatments of EC and EPC with SDF-1α increased EPC-EC interactions. There were more EPC associated with EC monolayers compared to single treatment (EC or EPC treated with SDF-1α). It suggested that stimulation of both EC and EPC with SDF-1α induce both types of cells to express elevated levels of E-selectin/lignad pairs that mediate stronger EPC-EC interactions. Both treatment of SDF-1α-stimulated EPC with E-selectin-neutralizing Ab and treatment of SDF-1α-stimulated HMVEC monolayers with sE-sel alone significantly inhibited EPC-EC interactions, but control Ab and BSA (Supplemental Figure 1) had no significant effect. Combination of E-selectin-neutralizing Ab and sE-sel showed even stronger inhibitory effect on EPC-EC interaction (Supplemental Figure 1). Overall, these results demonstrated that upregulated E-selectin on EPC and E-selecin ligands on EC are also responsible for mediating SDF-1α-enhanced EPC-EC interactions.
E-selectin on both EPC and wound endothelium are required for mediation of SDF-1α-induced EPC homing
To assess the involvement of SDF-1α-induced E-selectin on both EPC and wound endothelium in mediating EPC homing to wound tissue, syngeneic BM transplantation (BMT) was used to assess the homing capability of EPC derived from two types of donor mice, Rosa26+/− vs. Rosa26+/−;E-sel−/− in which LacZ+-BM cells, including EPC, either expressed or did not express E-selectin in response to SDF-1α (E-sel+/+-EPC vs. E-sel−/−-EPC), to wound tissues of two types of recipient mice, C57BL6 vs. E-sel−/− in which all tissue cells, including wound endothelium, expressed or did not express E-selectin (E-sel+/+-EC vs. E-sel−/−-EC). BM of γ-irradiated recipient mice (C57BL6 vs. E-sel−/−) were cross-reconstituted using LacZ+-BM cells from donor mice (infusion of LacZ+-BM cells from Rosa26+/− vs. Rosa26+/−;E-sel−/− mice (n = 6/group) into recipient mice (C57BL6 vs. E-sel−/−, n = 12/group)). Recipient mice were subjected to femoral ligation to create unilateral hindlimb ischemia and subsequent bilateral 4 mm cutaneous excision. γmSDF-1α was administered to wound bed. Recipient mice were killed after 7 days and half of mice (n = 6/group) were used to harvest wound tissues to perform IHC and the remaining mice (n = 6/group) were used for Dil-perfusion to measure neovascularization (see below). LacZ+-EPC that were recruited to wound tissues and incorporated into blood vessels were detected using double staining with X-gal (blue) and anti-CD31 (brown). We observed significantly less LacZ+/CD31+-EPC in blood vessels of ischemic wounds in the recipient C57BL6 mice which were transplanted with BMC from Rosa26+/−;E-sel−/− mice than that from Rosa26+/− mice (Fig. 4), indicating that E-selectin expressed on EPC is required for mediating SDF-1α-induced EPC homing. Consistent with previous observations, there were fewer LacZ+/CD31+-EPC in blood vessels of ischemic wounds in the recipient E-sel−/− mice than in those of C57BL6 mice (Fig. 4), confirming that E-selectin expressed in wound endothelium is also essential to mediation of SDF-1α-induced EPC homing.
E-selectin on both EPC and EC is essential to mediation of SDF-1α-induced neovascularization and re-perfusion in ischemic limb
The role of SDF-1α-induced E-selectin on EPC and on wound endothelium in regulation of neovascularization in wound tissue and perfusion in ischemic limb was explored. Neovascularization was evaluated by whole-body blood vessel Dil perfusion and subsequent laser scanning confocal microscopy in wound tissues harvested from recipient mice (n = 6/group) on day 7. Laser Doppler perfusion imaging (LDI) was used to confirm post-operative limb ischemia and quantify the spontaneous restoration of hindlimb blood flow over time (n = 12/group).
There was significantly higher blood vessel density in ischemic wounds (Fig. 5A) and increased mean flux measurements in the ischemic limb (Fig. 5B) of recipient C57BL6 mice transplanted with BMC (containing LacZ+-EPC) from Rosa26+/− mice compared to that from Rosa26+/−;E-sel−/− mice, indicating that E-selectin expressed on EPC is required for mediation of SDF-1α-induced neovascularization. Consistent with previous observations, there were fewer blood vessels within wounds (Fig. 5A) and decreased mean flux measurements in the ischemic limbs (Fig. 5B) in recipient E-sel−/− mice than in C57BL6 mice, confirming that E-selectin was expressed in wound endothelium and essential to mediation of SDF-1α-induced neovascularization and reperfusion of the ischemic limbs.
SDF-1α-induced E-selectin in both EPC and EC are critical for wound healing
The role of SDF-1α-induced E-selectin on EPC and on wound endothelium,in the regulation of wound healing was investigated. Wound areas were measured using daily digital photography until day 7 and calculated using ImageJ software. A delayed healing rate was observed in the recipient C57BL6 mice, which were transplanted with BMC from Rosa26+/−;E-sel−/− mice compared to that from Rosa26+/− mice (Fig. 6), indicating that E-selectin expressed on EPC is required for mediating SDF-1α-induced wound healing. Similarly, healing rate in recipient E-sel−/− mice was slower than in C57BL6 mice (Fig. 6), confirming that E-selectin expressed in wound endothelium is also relevant to mediation of SDF-1α-induced wound healing.
Luminal EC form a natural barrier between the blood and surrounding tissue. Under steady-state physiological conditions, luminal EC are mostly quiescent and form a tight, impermeable barrier. Under pathological conditions, such as tissue ischemia, inflammation and tumors, a variety of cytokines/chemokines, such as SDF-1α, TGF-ß and IL-1, are produced and released into tissue and the local tissue endothelium is stimulated by these soluble factors. It causes upregulation and activation of a unique panel of cell adhesion molecules (CAMs), including selectins and integrins, in the endothelium within the local tissue. This causes the local endothelium to switch from a tight impermeable to permeable and “sticky” status. These adhesion molecules act as docking sites and mediate tethering of circulating inflammatory cells and stem/ progenitor cells, including BMD-EPC. The anchored circulating cells undergo rolling, tight adhesion to the endothelium and subsequent transendothelial migration, extravasation from permeable capillaries and infiltration into diseased tissues. We previously demonstrated that SDF-1α upregulates E-selectin expression on the local wound endothelium and induces EPC to express E-selectin ligands10. The current study extend these findings and show that SDF-1α elevated or supplied in ischemic wound tissue has not only local but also remote effects, when it is released into circulation, on the expression of both E-selectin and its cognate ligands in wound endothelium and BMD-EPC. Upregulated dual E-selectin/ligand pairs reciprocally expressed in activated endothelium in wounds and mobilized BMD circulating EPC act as double locks, securing EPC-EC interactions by which to enhance selective homing of EPC to ischemic wound tissue, which is essential to neovascularization and tissue repair. In this way, the current findings provide profound and novel insight into the molecular mechanisms underlying the biological effects of SDF-1α on EPC homing and suggest that E-selectin and its ligands may be suitable targets and tools for therapeutic manipulation of targeted EPC homing. Full molecules, fragments and binding epitopes of E-selectin and its ligands may also be utilized to direct therapeutic stem cells, for instance, mesenchymal stem cells (MSC), homing to sites of ischemic lesions for cell-based therapy.
It is worth mentioning that there still remain debate with respect to the definition and function of EPC in the field. Murine EPC are defined as CD34+/KDR+ (in flow cytomery analysis) and LacZ+/CD31+ (in in vivo bone marrow transplantation experiments) in our study although these cells may also be generally referred as pro-angiogenic bone marrow-derived mononuclear cells. BM-derived circulating progenitor/stem cells, including EPC, can be incorporated into newly formed capillaries, enhance neovascularization after hind limb ischemia and improve tissue function after ischemic injury. Alternatively, recruited progenitor/stem cells, including EPC, may also promote neovascularization and tissue regeneration by releasing soluble factors, which act in a paracrine manner to support local angiogenesis and mobilize tissue residing progenitor cells.
The current study identified SDF-1α as a trigger to induce dual E-selectin/ligand pairs (all three types of ligands) to be reciprocally expressed on both activated endothelium in wound tissue and BMD-EPC. SDF-1α-induced ligands were found to be functional on both EPC and endothelium because they undergo post-translational modification (glycosylation), as indicated by increased association with HECA452, which specifically recognizes sLeX epitope on active PSGL-1/CD162 and CD4420,21. In addition, SDF-1α can mobilize BMD-EPC into circulation, although the precise role of induced E-selectin/ligand pairs in EPC mobilization is unclear. In this way, SDF-1α produced or presented in the local wound tissues play a pivotal role in the orchestration of a dynamic pro-angiogenic process in which both local and remote events are involved.
Although SDF-1α causes both EC and EPC to express dual E-selectin/ligand pairs, the quantity of E-selectin and ligands, especially the activity of ligands (extent of glycosylation post translation) in EC and EPC, do not appear to be equal. SDF-1α-induced E-selectin ligands expressed on EPC showed less modification than those expressed on EC (a weaker binding activity of EPC than EC to HECA452 as showed in Fig. 2C,D). This may be attributed to the differences in microenvironment between wound endothelium (for EC modification) and BM niche or circulation (for EPC modification). The quantities and activity of enzymes responsible for glycosylation vary in different microenvironments and may not depend upon SDF-1α. In other words, expression and modification of E-selectin ligands may be determined by different mechanisms. Less activated E-selectin ligands on EPC could be important because this may not result in aggregation of EPC in circulation, especially under disruption of blood flow. However, such lowly activated E-selectin ligands on EPC may enable association with highly expressed E-selectin on activated endothelium in the swampy, low-flow capillaries in the ischemic tissues, where highly activated E-selectin ligands on EC can bind with the E-selectin on EPC to enhance EPC-EC interactions, which is essential to EPC homing, using what is here described as a “double-lock” mechanism (Fig. 7). In addition, the number of circulating EPC in blood is very low (approximately 1 EPC/μl in peripheral blood according to our previous studies19. It must be pointed out that the number of EPC depends upon the methods used to define EPC). Thus, the chance for EPC to meet/interact in the circulating blood is low. Therefore, all these factors, including less activated E-selectin ligands on EPC, low amount of EPC in circulating blood and disruption of blood flow, prevent EPC from forming aggregates in the circulating blood. However, when circulating EPC arrive at the “swampy”, low-flow capillaries in the ischemic tissues, the local microenvironment (the quantities and activity of enzymes responsible for glycosylation of E-selectin ligands) may increase the activity of E-selectin ligands, which grants “double-lock” mechanism to work.
Roles of SDF-1α in retention of hematopoietic stem cells (HSC) in BM and recruited circulating mesenchymal stromal cells (MSC) in ischemic tissues have been reported6,22,23. SDF-1α-induced cell retention is ascribed to SDF-1α and its receptor CXCR4. Although it requires future study, our findings may suggest a potential role of up-regulated E-selectin/ligand pair on EPC in SDF-1α-induced retention of EPC in ischemic wound tissue. Because many tissue cells in ischemic limb and skin, including fibroblasts and inflammatory cells, express CD44 and/or CD162, E-selectin expressed on EPC can mediate cell-cell interaction between EPC and various tissue cells after EPC extravasate from blood vessels. Retention of EPC in ischemic tissue may be critical for neovascularization and tissue repair.
In summary, we report that SDF-1α elevated or therapeutically administered in ischemic wounded tissue can stimulate both local EC and BMD circulating EPC to express reciprocally E-selectin/ligand pairs and thereby enhance EPC-EC interactions. Our findings not only expand repertoire of SDF-1α and scope of SDF-1α-induced vascular adhesion molecules, but also identify a novel “double-lock” mechanism mediated by interaction of E-selectin/ligand pairs reciprocally expressed on the surface of both activated EC and EPC. Such a “double-lock” enhances and secures EPC-EC interactions by which to facilitate targeted EPC homing to ischemic wound tissue and subsequent EPC-associated neovascularization and repair responses. Further studies are warranted to address several important yet unanswered questions, for example, the molecular mechanisms underlying the regulation of E-selectin/ligand expression in EC and EPC by SDF-1α; the roles of each of these E-selectin ligands in mediating EPC-EC interaction.
Cells and mice
HMVEC, kindly provided by Dr. D. Fraker, University of Pennsylvania, Philadelphia, PA, were isolated from normal human dermis. Human EPC were purchased from NDRI (Philadelphia, PA). The same batch, but different passages of HMVEC and EPC were used in all experiments. Permission to use HMVEC and EPC was given from the ethics committee of University of Miami School of Medicine (IRB# 20080425) and complied to the Declaration of Helsinki. They were cultured as described previously10. C57 BL6 mice were purchased from Charles River (Wilmington, MA) and E-selectin−/− (E-sel−/−) (B6.129S4-seletmiDmil/J), Rosa26+/− (B6.129S7-GT (ROSA)26sor/J) which carry the LacZ gene and NOD (NOD/shilTJ) mice were from the Jackson Laboratory (Bar Harbor, ME). Rosa26+/−;E-sel−/− mice were generated by mating Rosa26+/− with E-sel−/− mice and subsequently mating Rosa26+/−;E-sel+/− with E-sel−/− mice using standard breeding methods and validated by genotyping. For BMT experiments, 5 × 106 bone marrow cells (BMC) from Rosa26+/− or Rosa26+/−;E-sel−/− mice were suspended in 200 μl of PBS and transplanted into γ-irradiated (850 rad) recipient E-sel−/− or C57 BL6 mice through tail vein 6 weeks before the experiment. Reconstitution of BM was validated 4–5 weeks after BMT by blood smear X-gal staining of recipient mice (>50% mononuclear cells in blood were LacZ+). Mice were maintained at the DVR animal facility under standard conditions and anesthetized for all surgical procedures by ketamine/xylazine (80/20 mg/kg, i.p.) and sacrificed in a CO2 chamber. All animal experimental protocols were approved by the Institutional animal care and use committee (IACUC) at the University of Miami. The methods were carried out in accordance with the approved guidelines.
Extracellular Matrix & Adhesion Molecule PCR Array quantitatively profiles 84 genes of adhesion molecules and ECM (PAHS-013Z, Qiagen, Valencia, CA). Subconfluent HMVEC and human EPC were stimulated with recombinant human (γh) SDF-1α protein (350-NS/CF, R&D Systems, Minneapolis, MN) vs. BSA at 100 ng/ml for 4 h (The dosage of γhSDF-1α (100 ng/ml) was pre-determined in our previous study10 based on the lowest concentration that could induce E-selectin expression in HMVEC). Total RNA was extracted using Trizol® (Invitrogen, Grand Island, NY). cDNA was synthesized using RT2 First Strand Kit (Qiagen). PCR array was carried out according to the manufacturer’s protocol. The threshold cycle (Ct) values were used to plot a standard curve. All samples were normalized to the relative levels of β-actin and results are expressed as fluorescence intensity in relative levels.
Murine BMC was harvested as previously described10. Murine blood samples were immediately placed on ice at 4 °C. After red cell lysis, BMC were incubated with FITC-CD34, APC-KDR and PE-E-selectin (#560238, 561252, #553751, BD Biosciences, San Jose, CA) or isotype-matched control Abs at 4 °C for 30 min using predetermined optimal concentrations of the test Abs. Cells were washed and analyzed using a FACScan flow cytometer (Becton Dickinson, San Jose, CA). EPC (CD34+/KDR+) were gated, counted and analyzed for levels of E-selectin. Five thousand cells were analyzed per sample.
The concentrations of SDF-1α in the sera of mice were measured using Quantikine® SDF-1α ELISA kit (DY460, R&D Systems) based on the manufacturer’s protocol.
Cell adhesion assay
HMVEC were cultured in 24-well plates to near confluency and stimulated with γhSDF-1α or BSA (100 ng/ml) and subsequently treated with soluble E-selectin (sE-sel, 10335-H08H, Sino Biological Inc., China) or BSA (2 μg/ml). 1 × 105 Dil-Ac-LDL-labeled EPC, which were pre-cultured on a 2% agarose-coated plate to prevent adhesion to the plate10, stimulated with γhSDF-1α or BSA and subsequently treated with either E-selectin-neutralizing Ab (BBA1; R&D Systems) or isotype-matched control Ab. These were added to wells containing HMVEC monolayer for 30 min at 37 °C. Unbound EPC were washed out with PBS (twice) and adherent Dil-Ac-LDL-labeled EPC were measured by fluorescence scanner (GE Typhoon Trio, Piscataway, NJ).
Immunoblotting and immunofluorescence
Immunoblotting was performed as described previously10,19. Subconfluent HMVEC and human EPC were stimulated with γhSDF-1α or BSA at 100 ng/ml for various periods as indicated. Cells were then harvested and subjected to immunoblotting as described10,19. Membranes were probed with Abs from Abcam (Cambridge, MA) to E-selectin (ab18981), CD162 (ab68143), CD44 (ab51037), ESL-1 (ab103439) and β-actin (AC-15). To assess CD44 expression in capillaries of ischemic wound tissues, sections were co-stained with FITC-CD44 and Alexa Fluor®594-CD31 (#103022, #102520, BioLegend, San Diego, CA) using immunofluorescence method as described previously10,19. In all immunofluorescence staining experiments, isotype-matched non-specific Ab was used as control (data not shown).
Active form of E-selectin ligand binding assay
Subconfluent HMVEC and human EPC were stimulated with γhSDF-1α and BSA (100 ng/ml) for 16 h in 96-well plates. After washing with PBS, 200 ng/well of FITC-HECA452 (#321306, BioLegend) vs. FITC-BSA (P8779, Sigma-Aldrich, St. Louis, MO) were added into well and incubated at 37 °C for 30 min. After being washed twice with PBS, the plates were scanned using a fluorescence scanner and fluorescent imaging was recorded using a fluorescence microscope. Samples were triplicated and experiments were repeated three times.
Laser Doppler perfusion imaging (LDI)
Limb perfusion was assessed daily using LDI (Periscan PIM II, Perimed AB, Sweden) as described previously10, Relative perfusion data are expressed as the ratio of the ischemic (right) to normal (left) limb blood flow.
Induction of mouse hindlimb ischemic wounds
Creation of mouse hindlimb ischemia (right limb), cutaneous wounds and wound bed injection of γmSDF-1α protein (460-SD/CF, R&D Systems) was conducted as described previously10.
Tissue-level detection of recruited BMD EPC
Frozen ischemic wound tissue sections were stained by X-gal (Fermentas, Canada) and HRP-anti-CD31 (ab28364, Abcam) and counterstained with nuclear fast red (Vector Labs) as described10. The number of EPC was quantified by counting LacZ+ cells in CD31+ vessels from 5 random high power fields (HPF, 20X) per section in at least 3 serial sections per wound sample (n = 6/group).
Blood vessel perfusion and laser scanning confocal microscopy
Mouse blood vessels were labeled by live perfusion with DiI (D-282, Invitrogen/Molecular Probes) solution and the vascular density was visualized by scanning the entire wound tissue to a depth of 200 μm, using laser scanning confocal microscopy (Vibratome (VT1000S, Leica Microsystems, Buffalo Grove, IL) as described10,15,24. Vessel density was quantified by assessing total number of Dil+ vessels normalized to the entire scanned wound area, using ImageJ software (Imaging Processing and Analysis in Java, National Institutes of Health, MD).
Assessment of wound closure rate
Wound area was measured with daily digital photographs and images were analyzed using ImageJ as described10,25. The wound’s relative recovery rate is expressed as [(original wound area minus daily wound area)/(original wound area)] X 100.
Statistical analysis of differences was performed using a 2-tailed Student’s t-test for two-group comparisons and two-way ANOVA test for multiple comparisons. Data are expressed as mean ± standard error of the mean (SEM). Values were considered statistically significant at P < 0.05. Statistical analyses were carried out with the SPSS 22.0 software package (SPSS, Inc., Chicago, IL, USA).
How to cite this article: Liu, Z.-J. et al. SDF-1α-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci. Rep. 6, 34416; doi: 10.1038/srep34416 (2016).
Liu, Z. J. & Velazquez, O. C. Hyperoxia, endothelial progenitor cell mobilization and diabetic wound healing. Antioxidants & redox signaling 10, 1869–1882, 10.1089/ars.2008.2121 (2008).
Deng, X. et al. New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis. Current pharmaceutical design 17, 1643–1651 (2011).
Chade, A. R. et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem cells 28, 1039–1047, 10.1002/stem.426 (2010).
Kawakami, Y. et al. SDF-1/CXCR4 axis in Tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 30, 95–105, 10.1002/jbmr.2318 (2015).
Hoenig, M. R., Bianchi, C. & Sellke, F. W. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Current drug targets 9, 422–435 (2008).
Abbott, J. D. et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110, 3300–3305, 10.1161/01.CIR.0000147780.30124.CF (2004).
Walter, D. H. et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circulation research 97, 1142–1151, 10.1161/01.RES.0000193596.94936.2c (2005).
Zimmermann, P. & David, G. The syndecans, tuners of transmembrane signaling. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 13 Suppl, S91–S100 (1999).
Iozzo, R. V. Matrix proteoglycans: from molecular design to cellular function. Annual review of biochemistry 67, 609–652, 10.1146/annurev.biochem.67.1.609 (1998).
Liu, Z. J. et al. Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing. Annals of surgery 252, 625–634, 10.1097/SLA.0b013e3181f5a079 (2010).
Luster, A. D., Alon, R. & von Andrian, U. H. Immune cell migration in inflammation: present and future therapeutic targets. Nature immunology 6, 1182–1190, 10.1038/ni1275 (2005).
Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature reviews. Immunology 7, 678–689, 10.1038/nri2156 (2007).
Sreeramkumar, V. et al. Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice. Blood 122, 3993–4001, 10.1182/blood-2013-07-514497 (2013).
Oh, I. Y. et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 110, 3891–3899, 10.1182/blood-2006-10-048991 (2007).
Liu, Z. J. et al. Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin. Annals of surgery 254, 450–456; discussion 456-457, 10.1097/SLA.0b013e31822a72dc (2011).
Rivera-Nieves, J. et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. The Journal of experimental medicine 203, 907–917, 10.1084/jem.20052530 (2006).
da Costa Martins, P. et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arteriosclerosis, thrombosis and vascular biology 27, 1023–1029, 10.1161/ATVBAHA.107.140442 (2007).
Liu, Z. J. et al. Directing and Potentiating Stem Cell-Mediated Angiogenesis and Tissue Repair by Cell Surface E-Selectin Coating. PloS one 11, e0154053, 10.1371/journal.pone.0154053 (2016).
Gallagher, K. A. et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. The Journal of clinical investigation 117, 1249–1259, 10.1172/JCI29710 (2007).
Borges, E. et al. The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood 90, 1934–1942 (1997).
Dimitroff, C. J., Lee, J. Y., Rafii, S., Fuhlbrigge, R. C. & Sackstein, R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. The Journal of cell biology 153, 1277–1286 (2001).
Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988, 10.1016/j.immuni.2006.10.016 (2006).
Jiang, Q. et al. Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. Journal of molecular and cellular cardiology 56, 1–7, 10.1016/j.yjmcc.2012.12.016 (2013).
Li, Y. et al. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nature protocols 3, 1703–1708, 10.1038/nprot.2008.172 (2008).
Castilla, D. M. et al. A novel autologous cell-based therapy to promote diabetic wound healing. Annals of surgery 256, 560–572, 10.1097/SLA.0b013e31826a9064 (2012).
We would like to thank Dr. D. Fraker for providing HMVEC and the Imaging Core Facility at the University of Miami for assistance with laser scanning confocal microscopy and image quantification. This work was supported by grants from the National Institutes of Health (R01DK-071084 and R01GM081570) and a grant from the Wallace H. Coulter Center for Translational Research at the University of Miami.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Liu, Z., Tian, R., Li, Y. et al. SDF-1α-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia. Sci Rep 6, 34416 (2016). https://doi.org/10.1038/srep34416
Resveratrol prevents TNF-α-induced VCAM-1 and ICAM-1 upregulation in endothelial progenitor cells via reduction of NF-κB activation
Journal of International Medical Research (2020)
Injectable Silk Nanofiber Hydrogels for Sustained Release of Small-Molecule Drugs and Vascularization
ACS Biomaterials Science & Engineering (2019)
PLOS ONE (2018)
Intramuscular E-selectin/adeno-associated virus gene therapy promotes wound healing in an ischemic mouse model
Journal of Surgical Research (2018)
Russian Journal of Genetics (2018)